Moreover, since NG2 is also expressed in tumour cells of the mesenchymal phenotype, adipocytes, and cancer-associated fibroblasts (CAFs), its contribution to tumour progression appears to be even broader and more complex [57,58]. The gene discussed is CSPG4; the disease is neoplasm.